Friday, January 28, 2022: Payers

The CMS announced $49.4 million in grant funding to shore up enrollment and retention in Medicaid and the Children’s Health Insurance Program among parents, pregnant people, and children. The funding will go to state and local governments, tribal organizations,...

Friday, January 28, 2022: Life Sciences

Merck & Co. Inc. and Ridgeback Biotherapeutics LP said their COVID-19 antiviral pill, molnupiravir, was active against the Omicron variant in six lab studies. The drug’s effectiveness against Omicron hasn’t yet been studied in human trials. (Article...